HSBC Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $208M | Buy |
|
|||||
|
2025
Q2 | $190M | Sell |
|
|||||
|
2025
Q1 | $247M | Sell |
|
|||||
|
2024
Q4 | $309M | Buy |
|
|||||
|
2024
Q3 | $375M | Sell |
|
|||||
|
2024
Q2 | $384M | Sell |
|
|||||
|
2024
Q1 | $363M | Buy |
|
|||||
|
2023
Q4 | $286M | Buy |
|
|||||
|
2023
Q3 | $221M | Sell |
|
|||||
|
2023
Q2 | $217M | Buy |
|
|||||
|
2023
Q1 | $210M | Sell |
|
|||||
|
2022
Q4 | $186M | Buy |
|
|||||
|
2022
Q3 | $128M | Buy |
|
|||||
|
2022
Q2 | $93.5M | Buy |
|
|||||
|
2022
Q1 | $63.5M | Sell |
|
|||||
|
2021
Q4 | $61.8M | Sell |
|
|||||
|
2021
Q3 | $72.6M | Sell |
|
|||||
|
2021
Q2 | $73M | Sell |
|
|||||
|
2021
Q1 | $126M | Buy |
|
|||||
|
2020
Q4 | $60.9M | Buy |
|
|||||
|
2020
Q3 | $44.7M | Buy |
|
|||||
|
2020
Q2 | $47M | Buy |
|
|||||
|
2020
Q1 | $34.1M | Sell |
|
|||||
|
2019
Q4 | $33.4M | Sell |
|
|||||
|
2019
Q3 | $26.5M | Buy |
|
|||||
|
2019
Q2 | $26.7M | Buy |
|
|||||
|
2019
Q1 | $23.9M | Buy |
|
|||||
|
2018
Q4 | $19.5M | Sell |
|
|||||
|
2018
Q3 | $24M | Buy |
|
|||||
|
2018
Q2 | $15.7M | Sell |
|
|||||
|
2018
Q1 | $24.9M | Sell |
|
|||||
|
2017
Q4 | $57.3M | Buy |
|
|||||
|
2017
Q3 | $20M | Sell |
|
|||||
|
2017
Q2 | $30.8M | Sell |
|
|||||
|
2017
Q1 | $24.5M | Sell |
|
|||||
|
2016
Q4 | $23.7M | Buy |
|
|||||
|
2016
Q3 | $21.8M | Buy |
|
|||||
|
2016
Q2 | $16.2M | Sell |
|
|||||
|
2016
Q1 | $19.4M | Buy |
|
|||||
|
2015
Q4 | $28.2M | Sell |
|
|||||
|
2015
Q3 | $31.1M | Sell |
|
|||||
|
2015
Q2 | $49.1M | Sell |
|
|||||
|
2015
Q1 | $44.2M | Buy |
|
|||||
|
2014
Q4 | $36.1M | Buy |
|
|||||
|
2014
Q3 | $25.3M | Buy |
|
|||||
|
2014
Q2 | $16.6M | Sell |
|
|||||
|
2014
Q1 | $22.6M | Buy |
|
|||||
|
2013
Q4 | $17.4M | Buy |
|
|||||
|
2013
Q3 | $15.3M | Buy |
|
|||||
|
2013
Q2 | $7.7M | Buy |
|